Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gilles de la Tourette syndrome chromosome region, candidate 1 (GTSCR1) is a long non-coding RNA gene located on chromosome 18. It is not a protein-coding gene and has no evidence for acting as a therapeutic target, receptor, enzyme, or transporter. The gene has been implicated by location and association in Gilles de la Tourette syndrome and related tic disorders. Its exact biological function remains uncharacterized; its involvement in disease is based on genetic studies rather than on molecular intervention mechanisms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gilles de la Tourette syndrome chromosome region, candidate 1 (non-protein coding) (GTSCR1).